MedTech Business - February 27, 2017
Nine new installations in US for DigniCap
Dignitana announces that the DigniCap scalp cooling system, which was cleared in December 2015 by the FDA to reduce the likelihood of chemotherapy-induced hair loss in women with breast cancer, will soon be available in nine additional medical centers across the United States including the four locations of University of Miami Health System that were […]
Clinical Trials - August 7, 2014
Dignitana completes patient recruitment in pivotal trial
The medical cooling devices company announce that it has completed patient recruitment in the multi-center pivotal trial of the patented DigniCap System. Dignitana is conducting a Premarket Approval (PMA), a regulatory process with the aim to obtain product and market approval for the DigniCap System in the United States (U.S.) by the Food and Drug […]
